|
Once pharmaceutical product candidates have concluded the early
development stage, it is the strategy to out-license product candidates
through strategic and long-standing relationships with international
renowned pharmaceutical companies. These relations provide the
expertise and resources to accelerate the development process to the
objective of commercialization.
|